T1	intervention 0 11	Venlafaxine
T2	control 19 28	clonidine
T3	outcome 875 896	reduction in HF score
T4	iv-bin-abs 901 904	49%
T5	cv-bin-abs 925 928	55%
T6	outcome 715 753	Premature discontinuation for toxicity
T7	iv-bin-abs 766 768	14
T8	cv-bin-abs 795 796	5
T9	intervention-participants 769 771	59
T10	control-participants 797 799	53
T11	intervention-participants 651 657	Thirty
T12	control-participants 696 698	30
T14	total-participants 417 419	60
T15	eligibility 420 458	breast cancer patients experiencing HF
T16	condition 50 61	hot flashes
T17	outcome 1016 1028	HF reduction
